244 related articles for article (PubMed ID: 34512899)
1. Borderline resectable for colorectal liver metastases: Present status and future perspective.
Kitano Y; Hayashi H; Matsumoto T; Kinoshita S; Sato H; Shiraishi Y; Nakao Y; Kaida T; Imai K; Yamashita YI; Baba H
World J Gastrointest Surg; 2021 Aug; 13(8):756-763. PubMed ID: 34512899
[TBL] [Abstract][Full Text] [Related]
2. BRAF V600E potentially determines "Oncological Resectability" for "Technically Resectable" colorectal liver metastases.
Kobayashi S; Takahashi S; Nomura S; Kojima M; Kudo M; Sugimoto M; Konishi M; Gotohda N; Taniguchi H; Yoshino T
Cancer Med; 2021 Oct; 10(20):6998-7011. PubMed ID: 34535965
[TBL] [Abstract][Full Text] [Related]
3. Objective Definition and Optimized Strategy for "Biologically Borderline Resectable" Colorectal Liver Metastases.
Takamoto T; Nara S; Ban D; Mizui T; Murase Y; Esaki M; Shimada K; Hashimoto T; Makuuchi M
World J Surg; 2023 Nov; 47(11):2834-2845. PubMed ID: 37540268
[TBL] [Abstract][Full Text] [Related]
4. Multidisciplinary approach of liver metastases from colorectal cancer.
Adam R; Kitano Y
Ann Gastroenterol Surg; 2019 Jan; 3(1):50-56. PubMed ID: 30697610
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.
Huiskens J; Bolhuis K; Engelbrecht MR; De Jong KP; Kazemier G; Liem MS; Verhoef C; de Wilt JH; Punt CJ; van Gulik TM;
J Am Coll Surg; 2019 Dec; 229(6):523-532.e2. PubMed ID: 31520695
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature.
Guo M; Jin N; Pawlik T; Cloyd JM
World J Gastrointest Oncol; 2021 Sep; 13(9):1043-1061. PubMed ID: 34616511
[TBL] [Abstract][Full Text] [Related]
7. Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastases.
Kuiper BI; Abu Hilal M; Aldrighetti LA; Björnsson B; D'Hondt M; Dopazo C; Fretland ÅA; Isoniemi H; Philip Jonas J; Kazemier G; Lesurtel M; Primrose J; Schnitzbauer AA; Buffart T; Gruenberger B; Swijnenburg RJ; Gruenberger T
HPB (Oxford); 2024 May; 26(5):639-647. PubMed ID: 38373870
[TBL] [Abstract][Full Text] [Related]
8. Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective.
Shah K; Clary B
Minerva Chir; 2013 Feb; 68(1):49-76. PubMed ID: 23584266
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary approach to the diagnosis and treatment of patients with potentially resectable colorectal cancer liver metastasis: results of a multicenter study.
Han L; Xue J; Wu X; Liang G; Wu Y; Guo F; Gao S; Sun G
Ann Palliat Med; 2022 Feb; 11(2):717-729. PubMed ID: 35249349
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
[TBL] [Abstract][Full Text] [Related]
12. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
13. Conversion therapy combined with individualized surgical treatment strategy improves survival in patients with colorectal cancer liver metastases.
Ma R; Li T
Int J Clin Exp Pathol; 2021; 14(3):314-321. PubMed ID: 33786148
[TBL] [Abstract][Full Text] [Related]
14. [Hepatic metastasis of colorectal cancer--current therapeutic possibilities].
Popescu I; Alexandrescu S
Chirurgia (Bucur); 2010; 105(2):155-69. PubMed ID: 20540227
[TBL] [Abstract][Full Text] [Related]
15. Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group.
Bond MJG; Kuiper BI; Bolhuis K; Komurcu A; van Amerongen MJ; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grünhagen DJ; van Gulik T; Hermans JJ; de Jong KP; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Molenaar IQ; Neumann UP; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Kazemier G; May AM; Punt CJA; Swijnenburg RJ
Ann Surg Oncol; 2023 Sep; 30(9):5376-5385. PubMed ID: 37118612
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
17. Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group.
Nieuwenhuizen S; Puijk RS; van den Bemd B; Aldrighetti L; Arntz M; van den Boezem PB; Bruynzeel AME; Burgmans MC; de Cobelli F; Coolsen MME; Dejong CHC; Derks S; Diederik A; van Duijvendijk P; Eker HH; Engelsman AF; Erdmann JI; Fütterer JJ; Geboers B; Groot G; Haasbeek CJA; Janssen JJ; de Jong KP; Kater GM; Kazemier G; Kruimer JWH; Leclercq WKG; van der Leij C; Manusama ER; Meier MAJ; van der Meijs BB; Melenhorst MCAM; Nielsen K; Nijkamp MW; Potters FH; Prevoo W; Rietema FJ; Ruarus AH; Ruiter SJS; Schouten EAC; Serafino GP; Sietses C; Swijnenburg RJ; Timmer FEF; Versteeg KS; Vink T; de Vries JJJ; de Wilt JHW; Zonderhuis BM; Scheffer HJ; van den Tol PMP; Meijerink MR
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635230
[TBL] [Abstract][Full Text] [Related]
18. Current Surgical Management Strategies for Colorectal Cancer Liver Metastases.
Ivey GD; Johnston FM; Azad NS; Christenson ES; Lafaro KJ; Shubert CR
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205811
[TBL] [Abstract][Full Text] [Related]
19. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
[TBL] [Abstract][Full Text] [Related]
20. Strategies to convert to resectability the initially unresectable colorectal liver metastases.
Popescu I; Alexandrescu S; Croitoru A; Boros M
Hepatogastroenterology; 2009; 56(91-92):739-44. PubMed ID: 19621694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]